Publications
156 results found
Jabbour R, Ielasi A, Tanaka A, et al., 2017, A Hybrid Strategy With Bioresorbable Vascular Scaffolds And Drug Eluting Stents For Treating Complex Coronary Lesions, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 10, Pages: S25-S25, ISSN: 1936-8798
Tanaka A, Latib A, Kawamoto H, et al., 2017, Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy, EUROINTERVENTION, Vol: 12, Pages: 1730-1737, ISSN: 1774-024X
- Author Web Link
- Cite
- Citations: 59
Jabbour R, Ielasi A, Tanaka A, et al., 2017, CRT-100.78 A Hybrid Strategy With Bioresorbable Vascular Scaffolds And Drug Eluting Stents For Treating Complex Coronary Lesions, JACC: Cardiovascular Interventions, Vol: 10, Pages: S25-S25, ISSN: 1936-8798
Tanaka A, Jabbour RJ, Colombo A, 2017, Tips and tricks for implanting BRSs: Sizing, pre- and postdilatation, BIORESORBABLE SCAFFOLDS: FROM BASIC CONCEPT TO CLINICAL APPLICATIONS, Editors: Onuma, Serruys, Publisher: CRC PRESS-TAYLOR & FRANCIS GROUP, Pages: 470-476, ISBN: 978-1-4987-7974-6
Giannini F, Aurelio A, Jabbour RJ, et al., 2017, The coronary sinus reducer: clinical evidence and technical aspects, EXPERT REVIEW OF CARDIOVASCULAR THERAPY, Vol: 15, Pages: 47-58, ISSN: 1477-9072
- Author Web Link
- Cite
- Citations: 16
Spartera M, Godino C, Baldissera E, et al., 2017, Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease, AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, Vol: 7, Pages: 9-18, ISSN: 2160-200X
- Author Web Link
- Cite
- Citations: 8
Tanaka A, Jabbour RJ, Latib A, et al., 2016, Case illustration of the difference between bench test and in-vivo scaffold fracture thresholds, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 225, Pages: 20-22, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 1
Giannini F, Latib A, Jabbour RJ, et al., 2016, Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: 4-9, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 11
Tanaka A, Jabbour RJ, Kawamoto H, et al., 2016, Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds, JACC-CARDIOVASCULAR IMAGING, Vol: 9, Pages: 1469-1470, ISSN: 1936-878X
Mangieri A, Jabbour RJ, Tanaka A, et al., 2016, Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with bioresorbable scaffolds, JOURNAL OF CARDIOVASCULAR MEDICINE, Vol: 17, Pages: E149-E150, ISSN: 1558-2027
- Author Web Link
- Cite
- Citations: 3
Ancona MB, Tanaka A, Latib A, et al., 2016, Restored Physiological Vasomotion Imitating Intrascaffold Restenosis 3 Years After Bioresorbable Scaffold Implantation, CANADIAN JOURNAL OF CARDIOLOGY, Vol: 32, ISSN: 0828-282X
Tanaka A, Latib A, Kawamoto H, et al., 2016, Clinical Outcomes Following Bifurcation Double-Stenting With Bioresorbable Scaffolds, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 88, Pages: 854-862, ISSN: 1522-1946
- Author Web Link
- Cite
- Citations: 10
Tanaka A, Latib A, Jabbour RJ, et al., 2016, Impact of Angiographic Result After Predilatation on Outcome After Drug-Coated Balloon Treatment of In-Stent Coronary Restenosis, AMERICAN JOURNAL OF CARDIOLOGY, Vol: 118, Pages: 1460-1465, ISSN: 0002-9149
- Author Web Link
- Cite
- Citations: 26
Giannini F, Montorfano M, Romano V, et al., 2016, Valve embolization with a second-generation fully-retrievable and repositionable transcatheter aortic valve, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 223, Pages: 867-869, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 12
Tanaka A, Jabbour RJ, Kawamoto H, et al., 2016, Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 88, Pages: 865-870, ISSN: 1522-1946
- Author Web Link
- Cite
- Citations: 5
Yazdani KO, Jabbour RJ, Mangieri A, et al., 2016, A coronary solution to manage a vascular peripheral obstruction post transcatheter aortic valve implantation, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 222, Pages: 827-829, ISSN: 0167-5273
Tanaka A, Jabbour RJ, Kawamoto H, et al., 2016, Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 222, Pages: 674-675, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 1
Giannini F, Latib A, Montorfano M, et al., 2016, Comparison of the fully repositionable and retrievable Lotus Valve and Direct Flow Medical Valve for the treatment of severe aortic stenosis: a high-volume single center experience, 28th Annual Meeting of the Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B282-B282, ISSN: 0735-1097
- Author Web Link
- Cite
- Citations: 2
Tanaka A, Jabbour RJ, Latib A, et al., 2016, Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 88, Pages: 10-20, ISSN: 1522-1946
- Author Web Link
- Cite
- Citations: 8
Giannini F, Latib A, Jabbour RJ, et al., 2016, Impact of post-procedural hyperglycemia on acute kidney injury after transcatheter aortic valve implantation, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 221, Pages: 892-897, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 11
Pagnesi M, Martino EA, Chiarito M, et al., 2016, Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 221, Pages: 97-106, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 61
Ancona MB, Giannini F, Jabbour RJ, et al., 2016, Left main "Culotte in Culotte" to manage a trapped broken balloon, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 221, Pages: 347-349, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 1
Tanaka A, Jabbour RJ, Latib A, et al., 2016, Bioresorbable Scaffolds What Does "Less Forgiving" Mean?, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 9, Pages: 1856-1857, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 1
Jabbour RJ, Tanaka A, Pagnesi M, et al., 2016, T-Stenting With Small Protrusion The Default Strategy for Bailout Provisional Stenting?, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 9, Pages: 1853-1854, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 3
Hellen N, Owen T, Jabbour RJ, et al., 2016, Constitutive beta-adrenoceptor-mediated cAMP production controls spontaneous automaticity of human induced pluripotent stem cell-derived cardiomyocytes, Cardiovascular Research, Vol: 111, Pages: S17-S17, ISSN: 1755-3245
Pagnesi M, Jabbour RJ, Latib A, et al., 2016, Usefulness of Predilation Before Transcatheter Aortic Valve Implantation, AMERICAN JOURNAL OF CARDIOLOGY, Vol: 118, Pages: 107-112, ISSN: 0002-9149
- Author Web Link
- Cite
- Citations: 34
Tanaka A, Jabbour RJ, Kawamoto H, et al., 2016, Bioresorbable scaffold failure for recurrent restenosis at multi-layered stent fracture, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 214, Pages: 361-362, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 5
Mangieri A, Chieffo A, Montorfano M, et al., 2016, A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis?, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 214, Pages: 501-502, ISSN: 0167-5273
Lindsay AC, Harron K, Jabbour RJ, et al., 2016, Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation., Circulation: Cardiovascular Interventions, Vol: 9, ISSN: 1941-7640
BACKGROUND: Cardiovascular magnetic resonance (CMR) can provide important structural information in patients undergoing transcatheter aortic valve implantation. Although CMR is considered the standard of reference for measuring ventricular volumes and mass, the relationship between CMR findings of right ventricular (RV) function and outcomes after transcatheter aortic valve implantation has not previously been reported. METHODS AND RESULTS: A total of 190 patients underwent 1.5 Tesla CMR before transcatheter aortic valve implantation. Steady-state free precession sequences were used for aortic valve planimetry and to assess ventricular volumes and mass. Semiautomated image analysis was performed by 2 specialist reviewers blinded to patient treatment. Patient follow-up was obtained from the Office of National Statistics mortality database. The median age was 81.0 (interquartile range, 74.9-85.5) years; 50.0% were women. Impaired RV function (RV ejection fraction ≤50%) was present in 45 (23.7%) patients. Patients with RV dysfunction had poorer left ventricular ejection fractions (42% versus 69%), higher indexed left ventricular end-systolic volumes (96 versus 40 mL), and greater indexed left ventricular mass (101 versus 85 g/m(2); P<0.01 for all) than those with normal RV function. Median follow-up was 850 days; 21 of 45 (46.7%) patients with RV dysfunction died, compared with 43 of 145 (29.7%) patients with normal RV function (P=0.035). After adjustment for significant baseline variables, both RV ejection fraction ≤50% (hazard ratio, 2.12; P=0.017) and indexed aortic valve area (hazard ratio, 4.16; P=0.025) were independently associated with survival. CONCLUSIONS: RV function, measured on preprocedural CMR, is an independent predictor of mortality after transcatheter aortic valve implantation. CMR assessment of RV function may be important in the risk stratification of patients undergoing transcatheter aortic valve implantation.
Jabbour RJ, Colombo A, 2016, Bioresorbable scaffolds: the fee comes now and the reward comes later, FUTURE CARDIOLOGY, Vol: 12, Pages: 397-400, ISSN: 1479-6678
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.